Maxillary sinus surgery and use of fibrin-rich plasma: a systematic review

Detalhes bibliográficos
Autor(a) principal: Morais, Talysson Silva de Oliveira
Data de Publicação: 2024
Outros Autores: Costa, Abner da Rocha Cardoso, Idalgo, Fabio Alarcon, Cicareli, Alvaro José
Tipo de documento: Artigo
Idioma: eng
Título da fonte: MedNEXT Journal of Medical and Health Sciences
Texto Completo: https://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/346
Resumo: Introduction: In around 25% of all maxillary sinuses, there is an accessory bone that is located in a lower portion than the main ostium, and all the mucus produced and the particles trapped in this mucus are directed through the ciliary beat to the ostium. When a dental element is lost in the posterior region of the maxilla, there is natural reabsorption of the alveolar process and at the same time, pneumatization of the maxillary sinus occurs. Objective: It was to carry out a systematic review to elucidate the main clinical approaches to the use of fibrin-rich plasma in the bone regeneration process in maxillary sinus surgeries. Methods: The PRISMA Platform systematic review rules were followed. The search was carried out from October to December 2023 in the Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument. Results and Conclusion: A total of 115 articles were found, 40 articles were evaluated in full and 25 were included and developed in the present systematic review study. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 20 studies with a high risk of bias and 25 studies that did not meet GRADE and AMSTAR-2. Most studies did not show homogeneity in their results, with X2=55.5%<50%. It was concluded that to improve osseointegration and bone anchorage, surface modifications can be chemical, such as calcium phosphate (Ca-P), or physical impregnation, being related to the microtopography of the implant. Several variables affect the biological activity of FRP preparations, such as the number of centrifuges used, centrifugation speed, and other protocols that result in preparations with various volumes, platelet numbers, amount of growth factors, and concentration of fundamental white blood cells and erythrocytes. Some researchers recommend avoiding tissue exposure to FRP-containing leukocytes, arguing that an inflammatory reaction may occur. On the other hand, other authors have described beneficial effects due to increased immunological and antibacterial resistance, although there is no clinical evidence to support its effect. FRP has gained prominence in the scientific community because it does not require the addition of an activator or anticoagulant, making the product more autologous, and featuring a fibrin network that protects growth factors, keeping them in place for longer.
id FACERES-1_575844ceb93fba6d0a30d040aa67ae30
oai_identifier_str oai:ojs2.mednext.zotarellifilhoscientificworks.com:article/346
network_acronym_str FACERES-1
network_name_str MedNEXT Journal of Medical and Health Sciences
repository_id_str
spelling Maxillary sinus surgery and use of fibrin-rich plasma: a systematic reviewMaxillary sinus surgeryFibrin-rich plasmaBiomaterialsBone regenerationIntroduction: In around 25% of all maxillary sinuses, there is an accessory bone that is located in a lower portion than the main ostium, and all the mucus produced and the particles trapped in this mucus are directed through the ciliary beat to the ostium. When a dental element is lost in the posterior region of the maxilla, there is natural reabsorption of the alveolar process and at the same time, pneumatization of the maxillary sinus occurs. Objective: It was to carry out a systematic review to elucidate the main clinical approaches to the use of fibrin-rich plasma in the bone regeneration process in maxillary sinus surgeries. Methods: The PRISMA Platform systematic review rules were followed. The search was carried out from October to December 2023 in the Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument. Results and Conclusion: A total of 115 articles were found, 40 articles were evaluated in full and 25 were included and developed in the present systematic review study. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 20 studies with a high risk of bias and 25 studies that did not meet GRADE and AMSTAR-2. Most studies did not show homogeneity in their results, with X2=55.5%<50%. It was concluded that to improve osseointegration and bone anchorage, surface modifications can be chemical, such as calcium phosphate (Ca-P), or physical impregnation, being related to the microtopography of the implant. Several variables affect the biological activity of FRP preparations, such as the number of centrifuges used, centrifugation speed, and other protocols that result in preparations with various volumes, platelet numbers, amount of growth factors, and concentration of fundamental white blood cells and erythrocytes. Some researchers recommend avoiding tissue exposure to FRP-containing leukocytes, arguing that an inflammatory reaction may occur. On the other hand, other authors have described beneficial effects due to increased immunological and antibacterial resistance, although there is no clinical evidence to support its effect. FRP has gained prominence in the scientific community because it does not require the addition of an activator or anticoagulant, making the product more autologous, and featuring a fibrin network that protects growth factors, keeping them in place for longer.MetaScience Press2024-01-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/otherapplication/pdfhttps://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/34610.54448/mdnt24108MedNEXT Journal of Medical and Health Sciences; Vol. 5 No. 1 (2024): MedNEXT - February 2024MedNEXT Journal of Medical and Health Sciences; v. 5 n. 1 (2024): MedNEXT - February 20242763-5678reponame:MedNEXT Journal of Medical and Health Sciencesinstname:Faculdade de Medicina em São José do Rio Preto (Faceres)instacron:FACERESenghttps://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/346/321Copyright (c) 2023 Talysson Silva de Oliveira Morais, Abner da Rocha Cardoso Costa, Fabio Alarcon Idalgo, Alvaro José Cicarelihttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessMorais, Talysson Silva de OliveiraCosta, Abner da Rocha CardosoIdalgo, Fabio AlarconCicareli, Alvaro José2024-01-11T13:05:22Zoai:ojs2.mednext.zotarellifilhoscientificworks.com:article/346Revistahttps://mednext.zotarellifilhoscientificworks.com/index.php/mednextPUBhttps://mednext.zotarellifilhoscientificworks.com/index.php/mednext/oaimednextjmhs@zotarellifilhoscientificworks.com2763-56782763-5678opendoar:2024-01-11T13:05:22MedNEXT Journal of Medical and Health Sciences - Faculdade de Medicina em São José do Rio Preto (Faceres)false
dc.title.none.fl_str_mv Maxillary sinus surgery and use of fibrin-rich plasma: a systematic review
title Maxillary sinus surgery and use of fibrin-rich plasma: a systematic review
spellingShingle Maxillary sinus surgery and use of fibrin-rich plasma: a systematic review
Morais, Talysson Silva de Oliveira
Maxillary sinus surgery
Fibrin-rich plasma
Biomaterials
Bone regeneration
title_short Maxillary sinus surgery and use of fibrin-rich plasma: a systematic review
title_full Maxillary sinus surgery and use of fibrin-rich plasma: a systematic review
title_fullStr Maxillary sinus surgery and use of fibrin-rich plasma: a systematic review
title_full_unstemmed Maxillary sinus surgery and use of fibrin-rich plasma: a systematic review
title_sort Maxillary sinus surgery and use of fibrin-rich plasma: a systematic review
author Morais, Talysson Silva de Oliveira
author_facet Morais, Talysson Silva de Oliveira
Costa, Abner da Rocha Cardoso
Idalgo, Fabio Alarcon
Cicareli, Alvaro José
author_role author
author2 Costa, Abner da Rocha Cardoso
Idalgo, Fabio Alarcon
Cicareli, Alvaro José
author2_role author
author
author
dc.contributor.author.fl_str_mv Morais, Talysson Silva de Oliveira
Costa, Abner da Rocha Cardoso
Idalgo, Fabio Alarcon
Cicareli, Alvaro José
dc.subject.por.fl_str_mv Maxillary sinus surgery
Fibrin-rich plasma
Biomaterials
Bone regeneration
topic Maxillary sinus surgery
Fibrin-rich plasma
Biomaterials
Bone regeneration
description Introduction: In around 25% of all maxillary sinuses, there is an accessory bone that is located in a lower portion than the main ostium, and all the mucus produced and the particles trapped in this mucus are directed through the ciliary beat to the ostium. When a dental element is lost in the posterior region of the maxilla, there is natural reabsorption of the alveolar process and at the same time, pneumatization of the maxillary sinus occurs. Objective: It was to carry out a systematic review to elucidate the main clinical approaches to the use of fibrin-rich plasma in the bone regeneration process in maxillary sinus surgeries. Methods: The PRISMA Platform systematic review rules were followed. The search was carried out from October to December 2023 in the Scopus, PubMed, Science Direct, Scielo, and Google Scholar databases. The quality of the studies was based on the GRADE instrument and the risk of bias was analyzed according to the Cochrane instrument. Results and Conclusion: A total of 115 articles were found, 40 articles were evaluated in full and 25 were included and developed in the present systematic review study. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 20 studies with a high risk of bias and 25 studies that did not meet GRADE and AMSTAR-2. Most studies did not show homogeneity in their results, with X2=55.5%<50%. It was concluded that to improve osseointegration and bone anchorage, surface modifications can be chemical, such as calcium phosphate (Ca-P), or physical impregnation, being related to the microtopography of the implant. Several variables affect the biological activity of FRP preparations, such as the number of centrifuges used, centrifugation speed, and other protocols that result in preparations with various volumes, platelet numbers, amount of growth factors, and concentration of fundamental white blood cells and erythrocytes. Some researchers recommend avoiding tissue exposure to FRP-containing leukocytes, arguing that an inflammatory reaction may occur. On the other hand, other authors have described beneficial effects due to increased immunological and antibacterial resistance, although there is no clinical evidence to support its effect. FRP has gained prominence in the scientific community because it does not require the addition of an activator or anticoagulant, making the product more autologous, and featuring a fibrin network that protects growth factors, keeping them in place for longer.
publishDate 2024
dc.date.none.fl_str_mv 2024-01-11
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/other
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/346
10.54448/mdnt24108
url https://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/346
identifier_str_mv 10.54448/mdnt24108
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/346/321
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv MetaScience Press
publisher.none.fl_str_mv MetaScience Press
dc.source.none.fl_str_mv MedNEXT Journal of Medical and Health Sciences; Vol. 5 No. 1 (2024): MedNEXT - February 2024
MedNEXT Journal of Medical and Health Sciences; v. 5 n. 1 (2024): MedNEXT - February 2024
2763-5678
reponame:MedNEXT Journal of Medical and Health Sciences
instname:Faculdade de Medicina em São José do Rio Preto (Faceres)
instacron:FACERES
instname_str Faculdade de Medicina em São José do Rio Preto (Faceres)
instacron_str FACERES
institution FACERES
reponame_str MedNEXT Journal of Medical and Health Sciences
collection MedNEXT Journal of Medical and Health Sciences
repository.name.fl_str_mv MedNEXT Journal of Medical and Health Sciences - Faculdade de Medicina em São José do Rio Preto (Faceres)
repository.mail.fl_str_mv mednextjmhs@zotarellifilhoscientificworks.com
_version_ 1796798218350100480